Patents by Inventor Ralf Thomae

Ralf Thomae has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for prediction of prognosis of sepsis
    Patent number: 11041864
    Abstract: Disclosed is a prediction method for the prognosis of sepsis comprising measuring an sCD14-ST level in a sample. sCD14-ST, to be measured in the present invention, is a marker superior to procalcitonin, known as a marker to predict the prognosis in sepsis patients.
    Type: Grant
    Filed: January 10, 2012
    Date of Patent: June 22, 2021
    Assignees: LSI MEDIENCE CORPORATION, MOCHIDA PHARMACEUTICAL CO., LTD.
    Inventors: Takeshi Matsuya, Yoshikazu Okamura, Ralf Thomae, Eberhard Spanuth, Boris Ivandic, Kamon Shirakawa, Shigeatsu Endo
  • METHOD FOR PREDICTION OF PROGNOSIS OF SEPSIS
    Publication number: 20130288276
    Abstract: Disclosed is a prediction method for the prognosis of sepsis comprising measuring an sCD14-ST level in a sample. sCD14-ST, to be measured in the present invention, is a marker superior to procalcitonin, known as a marker to predict the prognosis in sepsis patients.
    Type: Application
    Filed: January 10, 2012
    Publication date: October 31, 2013
    Applicants: MOCHIDA PHARMACEUTICAL CO., LTD., Mitsubishi Chemical Medience Corporation
    Inventors: Takeshi Matsuya, Yoshikazu Okamura, Ralf Thomae, Eberhard Spanuth, Boris Ivandic, Kamon Shirakawa, Shigeatsu Endo